Frontiers in Drug Design and Discovery

Volume 7

by

Atta-ur-Rahman, Mohammad Iqbal Choudhary

DOI: 10.2174/97816810816561160701
eISBN: 978-1-68108-165-6, 2016
ISBN: 978-1-68108-166-3
ISSN: 1574-0889 (Print)
ISSN: 2212-1064 (Online)



Indexed in: Scopus, EMBASE, EBSCO, Ulrich's Periodicals Directory.

Frontiers in Drug Design and Discovery is an eBook series devoted to publishing...[view complete introduction]
US $
Buy Personal eBook
99
Order Library eBook
396
Order Printed Copy
*119
Order PDF + Printed Copy (Special Offer)
*168

*(Excluding Mailing and Handling)

🔒Secure Checkout Personal information is secured with SSL technology
Download Flyer

Nanotherapeutics: Future Medicine For Infectious Diseases

- Pp. 248-297 (50)

Priyanka S. Prabhu, Vandana B. Patravale, Khurshid I. Andrabi and Farooq A. Shiekh

Abstract

Infectious diseases are increasingly becoming a major health concern annually afflicting millions of humans worldwide. Presently, the greatest challenge to any successful effective treatment of a particular pathogen is the emergence of drugresistance, less bioavailability and non-specificity of potent antibiotics at the target sites, requiring large doses of medicine over a longer period of time, resulting in maximum toxicity to patients. However, drug delivery is a powerful concept in nanomedicine which is constantly growing at a burgeoning pace, could provide an efficient alternative to target any pathogens at any site in the body using advanced combined nanoparticle platforms or nanocarriers with fewer side effects. Significantly, nanotherapeutics could be administered through various specific routes such as oral, parenteral, and topical for effective treatment. </p><p> In summary, this chapter would highlight the role of targeted antibiotics as an advancement of future nanomedicine over conventional therapeutics against virulent infectious diseases.

Purchase Chapter  Book Details

Advertisement


Webmaster Contact: info@benthamscience.net Copyright © 2019 Bentham Science